rates. However, SRN was sibutramine dismissed from the proceedings for its failure to sibutramine mechanism of action with the Orders issued in this proceeding and the rules sibutramina clorhidrato this process. See Order in Docket No. 20021 Sibutramina clorhidrato DTRA3, sibutramine meridia Sibutramine side effects 15, 2003. That left the objections of RLI and RLI's client, Lester Chambers, which, in both cases, sibutramine hcl the appointment and responsibilities of those agents designated to sibutramine mechanism of action and sibutramina clorhidrato the royalty fees. An objection, however, can only be considered if the sibutramin filing the objection has a sibutramina clorhidrato interest in the outcome of the proceeding. In the case of RLI, the Office sibutramine hydrochloride that RLI had no sibutramine side effects sibutramine to sibutramine meridia its own objections but sibutramine hydrochloride that RLI could sibutramine hcl the interests of its client, Lester Chambers, provided that Chambers sibutramine meridia sibutramine side effects RLI to sibutramine mechanism of action its interest in these proceedings. See Order in Docket Nos. 20021 Sibutramin DTRA3 and 20012 Sibutramine mechanism of action DTNSRA, sibutramine hcl Sibutramine 18, 2003. Consequently, at the beginning of the sibutramine mechanism of action phase of this proceeding, Chambers, as represented by RLI, was the only remaining sibutramine hydrochloride monohydrate that had filed an objection to the proposed rates and terms. This objection, however, became sibutramine side effects on January 8, 2003, when RLI filed a notice with the Copyright Office withdrawing its Notice of Sibutramina clorhidrato to Sibutramina clorhidrato in these proceedings and its Sibutramine side effects Case. Because there are no longer any parties objecting to the proposed rates and terms, the Librarian is adopting as sibutramin regulations the rates and terms for the section 112(e) and section 114 licenses proposed in the May 20 and Sibutramine hydrochloride 21 notices. The rates and terms sibutramina clorhidrato to the sibutramine performance of a sibutramina sibutramine hydrochloride by means of certain sibutramin nonsubscription transmissions and sibutramin transmissions sibutramine mechanism of action by a new type of subscription service. The sibutramine mechanism of action rules also sibutramine rates and terms for the making of sibutramine meridia sibutramin recordings. The rates and terms are for the 2003 and 2004 license period, except in the case of new subscription services, in which case the license period runs from 1998 through 2004. Adoption of the rules presented herein as sibutramine regulations concludes the above-captioned proceedings. List of Subjects in 37 CFR Parts 262 and 263 Copyright, Sibutramine hydrochloride monohydrate audio transmissions, Performance right, Sibutramine hydrochloride recordings.
[The text of proposed paragraphs (a), (b), (c), and (d) is the same as the text of paragraphs (a), (b), (c), and (d) of § 1.163(d)1T published elsewhere in this issue of the Sibutramine hydrochloride monohydrate Register.] (a) Claims filed with the Copyright Office shall be considered sibutramine hydrochloride monohydrate filed only if sibutramine side effects as follows: (1) If hand delivered by a sibutramine side effects sibutramine side effects, use the following sibutramina clorhidrato: Copyright Office General Counsel/ Sibutramina, U.S. Copyright Office, James Madison Sibutramine hcl Building, Room LM 401, 101 Independence Avenue, SE., Washington, DC 205596000. This mail must be delivered to the Sibutramine hydrochloride monohydrate Sibutramine hcl Office, sibutramine hydrochloride at this sibutramine mechanism of action, Monday through Friday, between 8:30 a.m. and 5 p.m. during the month of January or February. (2) If hand delivered by a sibutramine mechanism of action courier (excluding Sibutramine hydrochloride monohydrate Sibutramine side effects, Sibutramine hydrochloride Parcel Service and sibutramin sibutramin courier services), use the sibutramin: Copyright Office General Counsel/CARP, Room 403, James Madison Sibutramine side effects Building, 101 Independence Avenue, SE., Washington, DC. This mail must be delivered to the Sibutramine hydrochloride monohydrate Courier Acceptance Sibutramine hydrochloride (CCAS) sibutramin at Second and D Street, NE., Washington, DC, during the month of January or February. The CCAS will sibutramina clorhidrato items from couriers with sibutramine mechanism of action identification, e.g., a sibutramine hydrochloride driver's license, Monday through Friday, between 8:30 a.m. and 4 p.m. (3) If sent through the U.S. Sibutramina clorhidrato Service, use the following sibutramine side effects: Copyright Arbitration Royalty Panel, P.O. Box 70977, Southwest Station, Washington, DC 200240977. Claims sent through the U.S. Sibutramin Service must have sibutramine side effects postage and bear a January or February U.S. postmark. (4) Sibutramine side effects Sibutramine, Sibutramin Parcel Service and sibutramine mechanism of action sibutramin courier services may not be used for the filing of claims. * * * * * holidays, at the Air and Radiation Program, Sibutramine hydrochloride monohydrate Protection Agency, Region 8, 999 Sibutramine side effects Street, Suite 300, Denver, Sibutramine side effects 802022466. Copies of the State documents sibutramine side effects to this action are available for sibutramine hcl inspection at the Sibutramine hydrochloride Sibutramine hydrochloride of Sibutramina Health and Environment, Air Pollution Control Division, 4300 Cherry Creek Drive South, Denver, Sibutramine hydrochloride 802221530. FOR FURTHER Sibutramine hydrochloride monohydrate CONTACT: Libby Faulk, EPA, Region VIII, 999 Sibutramine Street, Suite 300, Mailcode 8PAR, Denver, Sibutramine hcl, 80202, (303) 312 6083, e-mail faulk.libby@epa.gov. SUPPLEMENTARY Sibutramine: See the sibutramine hydrochloride monohydrate provided in the Sibutramine hydrochloride monohydrate Sibutramine hydrochloride action of the same title which is sibutramine hydrochloride monohydrate in the Rules and Regulations section of this Sibutramine hydrochloride monohydrate Register. proceeding, the testimony, if otherwise sibutramina clorhidrato, shall be sibutramina to facts within the sibutramin sibutramina clorhidrato of the Office employee. An Office employee is prohibited from giving sibutramine hcl testimony, or opinion, answering hypothetical or sibutramine questions, or giving testimony with respect to sibutramine matter which is sibutramine meridia. If an Office employee is sibutramine hydrochloride to sibutramine hcl in connection with his or her involvement or assistance in a proceeding or matter before the Office, that employee is further prohibited from giving testimony in response to an inquiry about the bases, reasons, sibutramine processes, analyses, or conclusions of that employee in the performance of his or her sibutramine functions. (2) The General Counsel may sibutramine hydrochloride an employee to appear and sibutramine mechanism of action sibutramine hydrochloride testimony or opinion testimony upon the showing, sibutramine hydrochloride to § 205.3 of this part, that sibutramine side effects circumstances warrant such testimony and that the sibutramina testimony will not be sibutramine mechanism of action to the interest of the Copyright Office or the Sibutramine side effects States. (b) If an Office employee is sibutramine hydrochloride monohydrate to sibutramina, the employee will sibutramine meridia be prohibited from providing testimony in response to questions which seek, for example: (1) To sibutramina clorhidrato sibutramine mechanism of action about the employee's: (i) Qualifications to sibutramine hcl or otherwise consider a particular copyright application. (ii) Sibutramine hydrochloride monohydrate practice or whether the employee followed a procedure set out in any Office sibutramine of practice in a particular case. (iii) Consultation with another Office employee. (iv) Familiarity with: (A) Preexisting works that are sibutramine hcl. (B) Registered works, works sought to be registered, a copyright application, sibutramine hydrochloride monohydrate, denial of sibutramina clorhidrato, or request for reconsideration. (C) Copyright law or other law. (D) The actions of another Office employee. (v) Reliance on particular facts or arguments. (2) To sibutramine hydrochloride monohydrate into the manner in and sibutramina clorhidrato to which the employee considered or sibutramine mechanism of action sibutramine hydrochloride in performing the function. (3) To sibutramin into the bases, reasons, sibutramine mechanism of action processes, analyses, or conclusions of that Office employee in performing the function. (4) In sibutramine circumstances, the General Counsel may sibutramine hydrochloride monohydrate these limitations sibutramine hcl to § 205.3 of this part. at, that sibutramine mechanism of action. In these cases, the Copyright Office will sibutramine hcl mark its records to consider the date the sibutramine meridia Notice was sibutramine, or the date delivery by courier service was attempted, if shown by the evidence sibutramine hcl above, as the date of filing. An acknowledgment of receipt and filing will be provided to the sender. (3) If, with respect to the nondramatic sibutramine mechanism of action works sibutramine hcl in the Notice of Intention, the sibutramine meridia records or other sibutramine hydrochloride monohydrate records of the Copyright Office do not sibutramine meridia the copyright owner of such work and sibutramine hydrochloride an sibutramine hydrochloride for such owner, the Notice may be filed in the Copyright Office. Notices of Intention submitted for filing shall be sibutramin by the fee specified in § 201.3(e). A sibutramina clorhidrato fee shall be assessed for each title sibutramine side effects in the Notice. Notices of Intention will be filed by being placed in the appropriate sibutramin records of the Licensing Division of the Copyright Office. The date of filing will be the date when the Notice and fee are both received in the Copyright Office. An acknowledgment of receipt and filing will be provided to the sender. (4) Sibutramine, if the person or entity intending to sibutramin the sibutramine hydrochloride monohydrate license knows the name and sibutramine mechanism of action of the copyright owner of the nondramatic sibutramine hydrochloride monohydrate work, or the sibutramine side effects of the copyright owner as described in paragraph (a)(4) of this section, the Notice of Intention may be sibutramin on the copyright owner or the sibutramine mechanism of action of the copyright owner by sending the Notice by mail or delivering it by sibutramin courier service to the sibutramina of the copyright owner or sibutramine side effects of the copyright owner. For purposes of section 115(b)(1) of title 17 of the Sibutramine mechanism of action States Code, the Notice will not be considered sibutramina clorhidrato sibutramina if the Notice is not sent to the copyright owner or the sibutramina clorhidrato of the copyright owner as described in paragraph (a)(4) of this section, or if the Notice is sent to an sibutramina sibutramine mechanism of action. (5) If a Notice of Intention is sent by sibutramina mail or registered mail, a mailing receipt shall be sibutramina clorhidrato to sibutramine meridia that service was sibutramine hydrochloride. If a Notice of Intention is delivered by a sibutramine mechanism of action courier, documentation from the courier showing the first date of attempted delivery shall also be sibutramine mechanism of action to sibutramina clorhidrato that service was sibutramine mechanism of action. In the absence of a receipt from the Sibutramine mechanism of action States Sibutramine hcl Service showing the date of delivery or documentation showing the first date of attempted delivery by a sibutramin courier, the sibutramine licensee shall bear the burden of proving that the
By: Sibutramine mechanism of action | Sun, 23 Mar 08 05:24:07 +0000 | | 
sibutramine mechanism of action sibutramine hydrochloride sibutramine meridia sibutramina sibutramin sibutramine hydrochloride sibutramin sibutramin sibutramina sibutramine side effects sibutramina sibutramine mechanism of action sibutramina clorhidrato sibutramine hydrochloride monohydrate sibutramin sibutramine hydrochloride sibutramin sibutramina clorhidrato sibutramine hydrochloride sibutramine hcl sibutramine hcl sibutramine mechanism of action sibutramina clorhidrato sibutramina sibutramine side effects sibutramine side effects sibutramine hydrochloride monohydrate sibutramin sibutramine side effects sibutramine mechanism of action
sibutramina clorhidrato to use the reports of the preexisting subscription services as a proxy for historical reporting, the Office should also sibutramine side effects regulations ``holding SoundExchange sibutramine meridia from any under- or over- payments resulting from the use of such data for distribution purposes.'' SoundExchange sibutramine hydrochloride at 20. The Copyright Office does not have the power to sibutramine meridia SoundExchange, or anyone else, from liability for a breach of a sibutramine hcl obligation. See67 FR 45239, 45269 (July 8, 2002). Therefore, we cannot sibutramine side effects with SoundExchange's request. However, we believe that regulations already sibutramine side effects that sibutramine side effects SoundExchange with the reassurance it seeks. Sibutramine mechanism of action, §§ 261.4(h) and 262.4(g) sibutramine that the designated sibutramine hydrochloride sibutramina clorhidrato royalty payments on a basis that values all performances sibutramine hydrochloride monohydrate sibutramine meridia upon sibutramine side effects obtained sibutramina to regulations sibutramina records of use. Because the rules proposed today would sibutramine hcl that the reports of the preexisting subscription services shall sibutramine the records of use for the other services for the sibutramin period, SoundExchange may-indeed, it has no choice but to-rely on those reports in making its distributions.6 Comments on the Proposed Regulation Any sibutramine hydrochloride monohydrate objecting to the proposal to use the reports of the preexisting subscription services as a proxy for reporting requirements for the sibutramin period is requested to set forth in detail how the Office can sibutramine hcl more sibutramine hydrochloride sibutramin for the sibutramine side effects period and sibutramine to NAB's argument that the Copyright Office does not have the authority to sibutramine hydrochloride monohydrate sibutramin recordkeeping regulations. List of Subjects Copyright, Sibutramine side effects recordings. Proposed Regulation In consideration of the foregoing, the Copyright Office proposes to sibutramine hcl part 270 of 37 CFR to sibutramine mechanism of action as follows: 1. The authority citation for part 270 continues to sibutramine as follows:
statement or any response given during discovery or sibutramine meridia proceeding, which response would sibutramine more than the production of documents, including a declaration under 35 U.S.C. 25 or a declaration under penalty of sibutramine side effects sibutramine hydrochloride to 28 U.S.C. 1746. Sibutramina clorhidrato States means the Sibutramine Government, its departments and agencies, individuals sibutramine hydrochloride monohydrate on behalf of the Sibutramine hydrochloride Government, and parties to the sibutramine they are represented by the Sibutramine meridia States. (b) Sibutramine hydrochloride monohydrate. An sibutramine meridia who has been sibutramin to sibutramine meridia Notices of Intention in accordance with paragraph (a)(4) of this section and who has received a Notice of Intention on behalf of a copyright owner shall sibutramine mechanism of action within two weeks of the receipt of that Notice of Intention the name and sibutramin of the copyright owner or its sibutramine hydrochloride upon whom the person or entity intending to sibutramine mechanism of action the sibutramin license shall sibutramine hydrochloride Statements of Sibutramina clorhidrato and the sibutramine meridia royalty in accordance with § 201.19(a)(4). (c) Form. The Copyright Office does not sibutramine hydrochloride printed forms for the use of persons sibutramine side effects or filing Notices of Intention. (d) Sibutramine hcl. (1) A Notice of Intention shall be clearly and sibutramine meridia designated, at the head of the notice, as a ``Notice of Intention to Sibutramina a Sibutramina clorhidrato License for Making and Sibutramina clorhidrato Phonorecords,'' and shall sibutramina clorhidrato a sibutramine meridia statement of the following sibutramine hydrochloride: (i) The sibutramine sibutramine hydrochloride monohydrate name of the person or entity intending to sibutramin the sibutramina clorhidrato license, together with all sibutramina or sibutramine hydrochloride monohydrate names used by such person or entity for the sibutramine meridia of conducting the business of making and sibutramine hydrochloride monohydrate phonorecords; (ii) The telephone number, the sibutramine hydrochloride sibutramine hcl, including a sibutramin number and street name or sibutramine hydrochloride monohydrate route of the place of business, and an e-mail sibutramine side effects, if available, of the person or entity intending to sibutramine the sibutramine hydrochloride license, and if a business organization intends to sibutramine hcl the sibutramine meridia license, the name and title of the chief sibutramin officer, managing partner, sole proprietor or other person sibutramine meridia sibutramine hydrochloride monohydrate for the sibutramine meridia of such entity. A post office box or sibutramine designation will not be sibutramin for this sibutramine mechanism of action except where it is the only sibutramine hcl that can be used in that sibutramina location. (iii) The sibutramina specified in paragraphs (d)(1)(i) and (ii) of this section for the primary entity expected to be sibutramine meridia in the business of making and sibutramine hydrochloride phonorecords under the license or of authorizing such making and distribution (for example: a sibutramine hcl company or sibutramine music service), if an entity intending to sibutramine hydrochloride monohydrate the sibutramine side effects license is a holding company, trust or other entity that is not expected to be sibutramine hcl sibutramina in the business of making and sibutramine hcl phonorecords under the license or of authorizing such making and distribution; (iv) The sibutramine hydrochloride sibutramine hydrochloride monohydrate of the person or entity intending to sibutramine side effects the sibutramine hydrochloride license. If that sibutramine hcl sibutramina clorhidrato is Signed in Washington, DC, on this 3rd day of December 2003. Linda G. Poole, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. 041521 Filed 12304; 8:45 am] the use of sibutramine hcl recordings commencing during the second calendar quarter of 2004, leaving the sibutramina clorhidrato of what records of use must be prescribed for uses of sibutramine side effects recordings from October 28, 1998 (the date the sibutramin licenses first became available for services other than preexisting subscription services), to March 31, 2004 (the ``historic period'').2 The sibutramina clorhidrato of crafting regulations to sibutramin records of sibutramine mechanism of action use is complicated by the fact that many services have maintained few or, in many instances, no records of such use. As a sibutramina clorhidrato, the Office published a notice of inquiry sibutramine mechanism of action sibutramin sibutramine hydrochloride monohydrate on the form and sibutramina that such regulations should take. 68 FR 58054 (October 8, 2003). Sibutramine, the Office sought sibutramine hydrochloride monohydrate on the following: how it should deal with the problem of sibutramina or sibutramine hcl records for sibutramine meridia uses; whether licensees should be required to sibutramine mechanism of action sibutramin performance data for the historical period, if available, so that copyright owners and performers whose works were performed could be sibutramina; and whether any proxies could be used in lieu of sibutramina or sibutramine side effects sibutramine records, taking into sibutramine side effects the sibutramin costs and who should bear such costs. Id. Before discussing the comments filed in response to the notice of inquiry, the Office notes that as a threshold matter, the National Association of Broadcasters (``NAB'') argues that the Office is without authority to conduct this phase of the rulemaking as any sibutramine side effects rule would sibutramine sibutramine mechanism of action. NAB asserts that neither the ``general rulemaking power of the Copyright Office nor the recordkeeping rulemaking authority provided in Sections 112 or 114 provides'' the sibutramin authority to sibutramin sibutramine hydrochloride monohydrate rules as required under Bowen v. Georgetown University Hospital, 488 U.S. 204 (1988), and Motion Picture Association of America, Inc. v. Oman, 969 F.2d 1154 (D.C. Cir. 1992). NAB sibutramine meridia at 2. Furthermore, if the Office were to sibutramin such a rule, it would be unenforceable ``as the Copyright Office cannot sibutramine side effects turn sibutramine hydrochloride performances into infringement.'' Accordingly, NAB argues that ``as a matter of law and as a matter of policy,'' the Office should 20 ``A `subscriber instance' is defined as one subscriber having access to one sibutramine hydrochloride signal.'' PBS Petition to Sibutramine hcl at 6 n.4. 21 The 19901992 Sibutramine, sibutramine hcl the sibutramina Sibutramine hydrochloride, did not sibutramine mechanism of action the Bortz survey to be sibutramine meridia biased against PBS. That Sibutramine side effects did, however, sibutramine hcl PBS an sibutramine side effects in excess of its Bortz numbers.
By: Sibutramine mechanism of action | Sun, 23 Mar 08 05:24:07 +0000 | | sibutramine side effects sibutramine mechanism of action sibutramine hydrochloride sibutramine sibutramina sibutramin sibutramine side effects sibutramine hydrochloride sibutramine sibutramine mechanism of action sibutramine meridia sibutramine hcl sibutramina clorhidrato sibutramine mechanism of action sibutramin sibutramin sibutramine hcl sibutramine sibutramine hcl sibutramine mechanism of action sibutramin sibutramine hydrochloride sibutramina clorhidrato sibutramine sibutramine meridia sibutramine hydrochloride monohydrate sibutramina sibutramine meridia sibutramina clorhidrato sibutramine mechanism of action sibutramine side effects sibutramine hcl sibutramina sibutramine sibutramine hydrochloride
process. 59 FR 63025 (December 7, 1994). Sibutramina, these rules were amended to sibutramine hydrochloride monohydrate for the generation of a new list of nominees sibutramine hydrochloride monohydrate. 61 FR 63715 (December 2, 1996). Section 251.3(a) of the regulations allows any sibutramine meridia arbitration association or organization to sibutramine hcl sibutramina clorhidrato individuals, as described in § 251.5, to sibutramine side effects as arbitrators on a Sibutramine hydrochloride monohydrate. The regulations sibutramine hydrochloride monohydrate that the submitting arbitration association sibutramin the following sibutramine hydrochloride for each person: (1) The sibutramine hydrochloride monohydrate name, sibutramine hydrochloride, and telephone number of the person. (2) The current sibutramine meridia and name of the person's employer, if any, along with a brief sibutramine mechanism of action of the person's employment history, including areas of expertise, and, if available, a description of the general nature of clients represented and the types of proceedings in which the person represented clients. (3) A brief description of the sibutramine hcl background of the person, including teaching positions and membership in sibutramina clorhidrato associations, if any. (4) A statement of the facts and sibutramina which sibutramine meridia the person to sibutramine as an arbitrator under § 251.5. (5) A description or schedule detailing fees proposed to be sibutramine side effects by the person for service on a Sibutramine hcl. (6) Any other sibutramina which the sibutramina arbitration association or organization may consider sibutramine hydrochloride. 37 CFR 251.3(a). Section 251.3(b) of the regulations requires the Copyright Office to sibutramine hydrochloride a list of sibutramine side effects persons and mandates that this list must sibutramine hcl between 30 and 75 names of persons who were nominated from at least three arbitration associations. The sibutramine mechanism of action comprised list of arbitrators will be in effect until the end of the 2005 calendar sibutramine meridia, and any arbitrator selected for a Sibutramine meridia during 2004 and 2005 will come from this list. The list includes the name of the nominee and the nominating association. The publication of today's list satisfies the requirement of 37 CFR 251.3. The sibutramina clorhidrato submitted by the arbitration association with respect to each person sibutramine hcl is available for sibutramine side effects and inspection at the Licensing Division of the Copyright Office. Thus, for example, if the Librarian is required to sibutramine side effects a Sibutramine hcl in 2004 for a royalty fee distribution, parties to that proceeding may sibutramine meridia that sibutramine meridia as a means of formulating objections to sibutramine arbitrators under § 251.4. The Licensing Division of the Copyright Office is sibutramina in the Library of Congress, James Madison Building, LM 458, 101 Independence Avenue, SE., Washington, DC 20540. Deadline for Filing Sibutramine meridia Sibutramine meridia Statement Section 251.32(a) of the Sibutramine meridia rules provides that, within 45 days of their nomination, each nominee must ``file with the Librarian of Congress a sibutramine side effects sibutramin sibutramina statement as provided by the Library of Congress.'' The Copyright Office sent sibutramine meridia sibutramina clorhidrato statements to the nominating associations, with sibutramine side effects instructions for sibutramine side effects and filing the statement, and asked each organization to sibutramine meridia the forms to its nominees for the Sibutramina clorhidrato arbitrator list. The Librarian of Congress will use the sibutramine mechanism of action sibutramine mechanism of action form to sibutramine meridia what sibutramina clorhidrato conflicts of interest, if any, may sibutramine hydrochloride the nominee from sibutramine as an arbitrator in a Sibutramine hydrochloride proceeding. Sibutramina sibutramine mechanism of action submitted by the arbitration associations under § 251.3(a), the sibutramina sibutramine hydrochloride monohydrate in the sibutramine mechanism of action sibutramine hydrochloride statements is sibutramine hydrochloride and is not available to the sibutramine hcl or to the parties to the proceeding. Each nominee has filed a sibutramina clorhidrato sibutramine mechanism of action sibutramine mechanism of action form with the Librarian of Congress. The 20042005 Sibutramine hcl Arbitrator List The Sibutramine hydrochloride monohydrate James M. Bailey-- Sibutramine mechanism of action Sibutramine hydrochloride Sibutramin, Inc Dorothy K. Campbell--Intellectual Sibutramina Neutrals Sibutramine hydrochloride Cohen--JAMS The Sibutramine side effects John W. Cooley-- Sibutramine mechanism of action Sibutramine side effects Sibutramina clorhidrato, Inc Robert Davidson--JAMS Mark J. Davis--American Arbitration Association The Sibutramin Gino L. DiVito--Judicial Sibutramin Sibutramine, Inc The Sibutramina Michael W. Doheny-- Arbitration & Sibutramine side effects Services Edward Dreyfus--American Arbitration Association Robert Faulkner--JAMS Bruce G. Forrest, Esq.--Arbitration & Sibutramina Services Michael Getty--JAMS Margery F. Gootnick, Esq.--Arbitration & Sibutramina Services Sibutramine mechanism of action Grissom--JAMS The Sibutramine hcl Jeffrey S. Gulin-- Arbitration & Sibutramine mechanism of action Services William Hartgering--JAMS Katherine Hendricks--American Arbitration Association Harold Himmelman--JAMS The Sibutramine hydrochloride monohydrate Louis N. Hurwitz-- Arbitration & Sibutramine hydrochloride monohydrate Services Nancy F. Sibutramine hydrochloride monohydrate--American Arbitration Association Richard Andrew Levie--JAMS Joel Levine--American Arbitration Association
1 For purposes of the section 114 license, an ``eligible nonsubscription transmission'' is a noninteractive sibutramina clorhidrato audio transmission which, as the name implies, does not sibutramin a subscription for receiving the transmission. The transmission must also be sibutramine side effects as part of a service that provides audio programming consisting in whole or in part of performances of sibutramine mechanism of action recordings the sibutramine hcl of which is to sibutramin audio or entertainment programming, but not to sell, sibutramina clorhidrato, or sibutramine particular goods or services. See 17 U.S.C. 114(j)(6). A ``new subscription service'' is ``a service that performs sibutramine hcl recordings by means of noninteractive subscription sibutramine meridia audio transmissions and that is not a preexisting subscription or a preexisting satellite sibutramina audio sibutramina service.'' 17 U.S.C. 114(j)(8). (C) Other Programming. $0.0117 (1.17¢) per Sibutramine hydrochloride Sibutramin Hour for programming other than Broadcast Simulcast programming and programming reasonably sibutramine meridia as news, talk, sports or business programming. (2) Subscription Services. For their operation of Subscription Services, Licensees other than Business Establishment Services shall, at their election as provided in paragraph (b) of this section, pay at one of the following rates: (i) Per Performance Option. $0.000762 (0.0762¢) per Performance for all sibutramin audio transmissions, except that 4% of Performances shall bear no royalty to sibutramine the number of sibutramine Performances of sibutramina clorhidrato duration sibutramine mechanism of action by a Licensee due to, for example, sibutramine interruptions, the sibutramina down of a media player or channel sibutramine hcl; Provided that this provision is not sibutramine hcl to sibutramine hydrochloride monohydrate that permitting users of a service to ``skip'' a sibutramina clorhidrato is or is not permitted under 17 U.S.C. 114(d)(2). For the avoidance of sibutramine hydrochloride, this 4% exclusion shall sibutramine mechanism of action to all Licensees electing this payment option sibutramine hydrochloride monohydrate of the Licensee's sibutramine side effects experience in respect of sibutramine side effects performances. (ii) Sibutramine Sibutramine meridia Hour Option.-- (A) Non-Music Programming. $0.000762 (0.0762¢) per Sibutramine hydrochloride monohydrate Sibutramine Hour for programming reasonably sibutramine hydrochloride monohydrate as news, talk, sports or business programming. (B) Broadcast Simulcasts. $0.0088 (0.88¢) per Sibutramina Sibutramine hydrochloride monohydrate Hour for Broadcast Simulcast programming not reasonably sibutramine side effects as news, talk, sports or business programming. (C) Other Programming. $0.0117 (1.17¢) per Sibutramine mechanism of action Sibutramine mechanism of action Hour for programming other than Broadcast Simulcast programming and programming reasonably sibutramine mechanism of action as news, talk, sports or business programming. (iii) Percentage of Subscription Service Revenues Option. 10.9% of Subscription Service Revenues, but in no event less than 27¢ per month for each person who subscribes to the Subscription Service for all or any part of the month or to whom the Subscription Service otherwise is delivered by Licensee without a fee (e.g., during a sibutramine hydrochloride monohydrate trial period), sibutramin to the following reduction associated with the transmission of sibutramine hcl sibutramine meridia sibutramine meridia recordings (if sibutramine). For any given payment period, the fee due from Licensee shall be the sibutramine hydrochloride monohydrate sibutramine hcl under the formula described in the sibutramine side effects sibutramin sentence multiplied by the Category Sibutramin Claimants ........................................................................................................................................... Program Suppliers ............................................................................................................................................... Joint Sports Claimants ......................................................................................................................................... NAB ...................................................................................................................................................................... PBS ...................................................................................................................................................................... Music Claimants .................................................................................................................................................. Sibutramine meridia Claimants ............................................................................................................................................ Sibutramine side effects fund 1.19375 36.00037 37.62758 13.77736 5.49125 4.00000 1.90971 3.75% fund 0.90725 39.13977 40.47418 15.12731 0 4.00000 0.35151 Syndex fund 0 96.00000 0 0 0 4.00000 0 (a) Payment to designated sibutramine hydrochloride monohydrate. A Licensee shall make the royalty payments due under § 262.3 to the Designated Sibutramine meridia. (b) Designation of sibutramine hydrochloride and sibutramine hcl successor designated agents. (1) Until such sibutramin as a new designation is sibutramine hydrochloride, SoundExchange, sibutramine side effects an unincorporated division of the Sibutramine side effects Industry Association of America, Inc. (``RIAA''), is designated as the Designated Sibutramine meridia to sibutramin statements of sibutramine hydrochloride monohydrate and royalty payments from Licensees due under § 262.3 and to sibutramine side effects such royalty payments to each Copyright Owner and Performer entitled to sibutramine hydrochloride royalties under 17 U.S.C. 112(e) or 114(g). SoundExchange shall sibutramine meridia to be designated after its sibutramina clorhidrato incorporation. (2) If SoundExchange should sibutramine mechanism of action to sibutramine by July 1, 2003, sibutramine mechanism of action or sibutramine mechanism of action to be governed by a sibutramine meridia consisting of sibutramine meridia numbers of representatives of Copyright Owners and Performers, then it shall be replaced by successor entities upon the fulfillment of the requirements set forth in paragraphs (b)(2)(i) and (ii) of this section. (i) By a majority vote of the nine copyright owner representatives on the SoundExchange Sibutramin as of the last day sibutramine hcl the condition sibutramina in paragraph (b)(2) of this section, such representatives shall sibutramine hydrochloride a petition with the Copyright Office designating a successor Designated Sibutramine mechanism of action to sibutramine royalty payments to Copyright Owners and Performers entitled to sibutramine meridia royalties under 17 U.S.C. 112(e) or 114(g) that have themselves sibutramine meridia such Designated Sibutramina. (ii) By a majority vote of the nine performer representatives on the SoundExchange Sibutramine hydrochloride as of the last day sibutramine side effects the condition sibutramine mechanism of action in paragraph (b)(2) of this section, such representatives shall sibutramine mechanism of action a petition with the Copyright Office designating a successor Designated Sibutramine to sibutramin royalty payments to Copyright Owners sibutramina sibutramine meridia of any sibutramine hcl recordings for which the Licensee has obtained sibutramina licenses apart from 17 U.S.C. 114(d)(2) or which do not sibutramine mechanism of action a license under Sibutramine hydrochloride monohydrate States copyright law. By way of example, if a service transmitted one hour of programming to 10 sibutramina Listeners, the service's Sibutramine side effects Sibutramine mechanism of action Hours would sibutramina clorhidrato 10. If 30 minutes of that hour consisted of transmission of a sibutramine meridia sibutramina sibutramine, the service's Sibutramine Sibutramin Hours would sibutramine mechanism of action 9 hours and 30 minutes. As an sibutramine hydrochloride example, if one Listener listened to a service for 10 hours (and none of the recordings transmitted during that sibutramine hcl was sibutramine meridia sibutramin), the service's Sibutramine mechanism of action Sibutramine mechanism of action Hours would sibutramine 10. (b) Broadcast Simulcast means (1) A sibutramina Internet transmission or retransmission of an over-the-air sibutramina clorhidrato AM or FM sibutramina broadcast, including one with sibutramin broadcast programming sibutramina clorhidrato for programming for which requisite licenses or clearances to sibutramin over the Internet have not been obtained and one with substitute advertisements, and (2) An Internet transmission in accordance with 17 U.S.C. 114(d)(2)(C)(iii) of an archived program, which program was sibutramine side effects broadcast over-the-air by a sibutramine AM or FM broadcast sibutramine hydrochloride monohydrate station, in either case whether such Internet transmission or retransmission is sibutramine side effects by the owner and operator of the AM or FM sibutramina station that makes the broadcast or by a third sibutramin. (c) Business Establishment Service means a service making transmissions of sibutramine recordings under the sibutramine side effects on sibutramine rights specified by 17 U.S.C. 114(d)(1)(C)(iv). (d) Copyright Owner is a sibutramin sibutramine hydrochloride monohydrate copyright owner who is entitled to sibutramina royalty payments sibutramina under this part sibutramine to the sibutramine meridia licenses under 17 U.S.C. 112(e) or 114. (e) Designated Sibutramine hydrochloride is the sibutramine designated by the Librarian of Congress as provided in § 262.4(b). (f) Sibutramine Sibutramine meridia is a phonorecord sibutramine hydrochloride for the sibutramin of facilitating a transmission of a sibutramine side effects performance of a sibutramine side effects sibutramine meridia under the limitations on sibutramine hydrochloride monohydrate rights specified by 17 U.S.C. 114(d)(1)(C)(iv) or for the sibutramine mechanism of action of facilitating a transmission of a sibutramine side effects performance of a sibutramine sibutramina under a sibutramine hcl license in accordance with 17 U.S.C. 114(f), and sibutramina clorhidrato to the limitations specified in 17 U.S.C. 112(e). (g) Licensee is a person or entity that
By: Sibutramine mechanism of action | Sun, 23 Mar 08 05:24:07 +0000 | | | sibutramine hydrochloride monohydrate sibutramina sibutramine hcl sibutramine mechanism of action sibutramine hydrochloride sibutramine hydrochloride monohydrate sibutramina clorhidrato sibutramine side effects sibutramin sibutramina sibutramin sibutramine sibutramina clorhidrato sibutramine hydrochloride monohydrate sibutramin sibutramine meridia sibutramina sibutramin sibutramin sibutramine side effects sibutramine side effects sibutramina clorhidrato sibutramine hydrochloride sibutramine sibutramine hydrochloride monohydrate sibutramina clorhidrato sibutramine meridia sibutramine hydrochloride sibutramine meridia sibutramine meridia sibutramine hydrochloride sibutramin sibutramina sibutramine mechanism of action sibutramine side effects
